Abstract:Background: In our previous paper, we demonstrated that Connexin 43 (CX43) was highly expressed in bladder cancer (BC) tissues. But the molecular mechanism about microRNAs (miRNAs) regulation upstream of CX43 in BC has not been well elucidated and remains to be further studied. MicroRNA-139-5p (miR-139-5p) is a tumor suppressor in progression of multifarious cancers including BC. Nevertheless, the underlying mechanisms of CX43/miR-139-5p in tumorigenesis of BC are still not well illustrated. The specific objective of our study was to inquiry the effect of CX43/miR-139-5p on BC progression and its underlying mechanism. Methods: The bioinformatics analysis softwares were applied to predict the miRNAs in the upstream of CX43. First, the expression levels of miR-139-5p in BC tissues (tumor) and paracancer tissues (normal) were investigated using the data from The Cancer Genome Atlas database. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was used to detect the mRNA expression level of miR-139-5p in three human BC cell lines 5637, T24, ECV-304 and a human bladder epithelial immortalized cell line SV-HUC-1 (normal control). Then si-CX43, si-control, miR-139-5p mimic, and its negative control (NC) were transfected into BC cell line ECV-304. The relationship of miR-139-5p and CX43 was analyzed by dual-luciferase reporter assay. The qRT-PCR and Western blotting were used to test the mRNA and protein expression level of CX43. The proliferation of ECV-304 and T24 cells were examined by cell counting kit-8. The migration and invasion of ECV-304 cells were tested by transwell assay. To determine whether miR-139-5p would affect cell proliferation, migration and invasion by targeting CX43, we executed the rescue assay. The comparison between two groups was analyzed by Student's t test, and comparisons among multiple samples were performed by one-way analysis of variance and a Bonferroni post hoc test. Results: The expression of miR-139-5p was remarkably down-regulated in BC tissues (tumor vs. normal, 2.286 +/- 0.017 vs. 3.211 +/- 0.034, t = 11.540, P < 0.0001) and cell lines (P < 0.01 in all BC cell lines). Besides, we also indicated that over-expression of miR-139-5p reduced the proliferation of ECV-304 (P = 0.001) and T24 cells (P = 0.005). Moreover, miR-139-5p over-expression weakened the invasion (P = 0.001) and migration (P = 0.001) of ECV-304 cells. Furthermore, the relative luciferase activity of CX43-wild type construct was distinctly lessened by up-regulation of miR-139-5p (miR-139-5p mimic NC vs. miR-139-5p mimic, 0.916 +/- 0.063 vs. 0.356 +/- 0.048, t = 7.085, P = 0.002), nevertheless the activity of CX43-mutant type construct was untouched (miR-139-5p mimic NC vs. miR-139-5p mimic, 0.918 +/- 0.057 vs. 0.878 +/- 0.039, t = 0.577, P = 0.595). Finally, the rescue assay revealed that CX43 deletion enhanced the depressor effect of miR-139-5p on ECV-304 cell proliferation (P < 0.01), invasion (P = 0.028), and migration (P = 0.014). Conclusion: MiR-139-5p, as a tumor-suppressor, repressed cell proliferation, invasion, and migration in BC, which might be achieved by regulating CX43.

P85 Alpha Inactivates Mmp-2 And Suppresses Bladder Cancer Invasion By Inhibiting Mmp-14 Transcription And Timp-2 Degradation

Oncogenic Role of MIR516A in Human Bladder Cancer Was Mediated by Its Attenuating PHLPP2 Expression and BECN1-dependent Autophagy.

PPARγ Inhibition Regulates the Cell Cycle, Proliferation and Motility of Bladder Cancer Cells

CRYAB Inhibits Migration and Invasion of Bladder Cancer Cells Through the PI3K/AKT and ERK Pathways.

LncRNA MBNL1-AS1 represses cell proliferation and enhances cell apoptosis via targeting miR-135a-5p/PHLPP2/FOXO1 axis in bladder cancer

Loss of PPM1A Expression Enhances Invasion and the Epithelial-to-mesenchymal Transition in Bladder Cancer by Activating the TGF-β/Smad Signaling Pathway

MicroRNA-3619-5p suppresses bladder carcinoma progression by directly targeting β-catenin and CDK2 and activating p21

Cxcl5/Cxcr2 Axis Promotes Bladder Cancer Cell Migration And Invasion By Activating Pi3k/Akt-Induced Upregulation Of Mmp2/Mmp9

ID2 Inhibits Bladder Cancer Progression and Metastasis via PI3K/AKT Signaling Pathway

p66 Suppresses Breast Cancer Cell Growth and Migration by Acting as Co-Activator of p53

Inhibition of MELK Produces Potential Anti‐tumour Effects in Bladder Cancer by Inducing G1/S Cell Cycle Arrest Via the ATM/CHK2/p53 Pathway

P16 Promotes the Growth and Mobility Potential of Breast Cancer Both in Vitro and in Vivo: the Key Role of the Activation of IL-6/JAK2/STAT3 Signaling

Mir-135a Enhances Cellular Proliferation Through Post-Transcriptionally Regulating PHLPP2 and FOXO1 in Human Bladder Cancer

Effects of Microrna-135A on the Epithelial–mesenchymal Transition, Migration and Invasion of Bladder Cancer Cells by Targeting GSK3β Through the Wnt/β-catenin Signaling Pathway

Knockdown of integrin β1 inhibits proliferation and promotes apoptosis in bladder cancer cells

MMP11 Promotes the Proliferation and Progression of Breast Cancer Through Stabilizing Smad2 Protein

MicroRNA-150-5p-mediated Inhibition of Cell Proliferation, G1/S Transition, and Migration in Bladder Cancer Through Targeting NEDD4-binding Protein 2-Like 1 Gene

Downregulation of LAPTM5 Suppresses Cell Proliferation and Viability Inducing Cell Cycle Arrest at G0/G1 Phase of Bladder Cancer Cells

Telomerase Suppression Initiates PML-dependent P53 Activation to Inhibit Bladder Cancer Cell Growth

Tumor-suppressor Microrna-139-5p Restrains Bladder Cancer Cell Line ECV-304 Properties Via Targeting Connexin 43

Targeting PPM1D by lentivirus-mediated RNA interference inhibits the tumorigenicity of bladder cancer cells.